1 / 40

Developing a Fluorescamine Assay to Probe Cardiac Protein Structure

Developing a Fluorescamine Assay to Probe Cardiac Protein Structure. Virginia Dines and Siddharth Damania 2006-2007. Thomas Biochemistry Lab University of Minnesota. Introduction. Nearly 60 million Americans suffer from heart disease

daniel_millan
Download Presentation

Developing a Fluorescamine Assay to Probe Cardiac Protein Structure

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Developing a Fluorescamine Assay to Probe Cardiac Protein Structure Virginia Dines and Siddharth Damania 2006-2007

  2. Thomas Biochemistry Lab University of Minnesota

  3. Introduction • Nearly 60 million Americans suffer from heart disease • Cardiac muscles require calcium to flow through the membrane calcium pump to beat Used with Permission from Dr. Thomas

  4. Phospholamban Robia, Flohr & Thomas (2005), Biochemistry 44: 4302 – 4311 Oxenoid & Chou (2005), PNAS 102: 10870 – 10875

  5. Phospholamban

  6. Phospholamban

  7. Spin Label

  8. Spin Label

  9. Phospholamban

  10. Phospholamban

  11. Phospholamban

  12. Fluorescamine

  13. Fluorescamine

  14. Fluorescamine

  15. Background • Study by Udenfriend et al. (1972) showed that when fluorescamine is reacted with primary amines (in lysine and PLB), the fluorescent intensity of the fluorophor increases linearly

  16. Goals • Develop a fluorescamine assay

  17. Goals • Develop a fluorescamine assay • Optimize the fluorescamine assay

  18. Goals • Develop a fluorescamine assay • Optimize the fluorescamine assay • Use the assay to assess the spin-labeling success in phospholamban

  19. Fluorescamine Assay • Measure the fluorescent intensity of fluorescamine bound to lysine, PLB, and labeled PLB in increasing concentrations to ultimately determine spin-labeling success rate

  20. Fluorescamine Assay with Lysine

  21. Fluorescamine Assay of PLB and Lysine

  22. Fluorescamine Assay with Arginine

  23. Spin Label Controls: DMF

  24. Spin Label Controls: SUCSL in DMF

  25. Fluorescamine Assay with Spin Labeled PLB

  26. Fluorescamine Assay with Spin Labeled PLB Subtracting Spin Label Control Shows 33% Labeled PLB

  27. Fluorescamine Time Control

  28. Conclusions • A lysine standard curve cannot be used to quantify PLB because of structural differences

  29. Conclusions • A lysine standard curve cannot be used to quantify PLB because of structural differences • The spin label binds to fluorescamine and forms a fluorescent compound

  30. Conclusions • A lysine standard curve cannot be used to quantify PLB because of structural differences • The spin label binds to fluorescamine and forms a fluorescent compound • Fluorescamine solution increases in fluorescence over time

  31. Future Work • Control the increasing fluorescence using a 96-well microplate reader http://openwetware.org/images/c/c7/Macintosh_HD-Users-nkuldell-Desktop-RTPCRplate.png

  32. Future Work • Apply fluorescamine assay to determine efficiency of spin-labeling PLB

  33. Future Work • Determine structure of pentameric phospholamban and further investigate how PLB interacts with the calcium pump

  34. Acknowledgements • Dr. David D. Thomas • Kurt Torgersen • The University of Minnesota • Ms. Lois Fruen • Team Research

  35. Developing a Fluorescamine Assay to Probe Cardiac Protein Structure Virginia Dines and Siddharth Damania 2006-2007

More Related